Sequential changes of KL-6 in sera of patients with interstitial pneumonia associated with polymyositis/dermatomyositis

• Published in: Annals of the rheumatic diseases 2000-04, Vol.59 (4), p.257-262
• Main Authors: Bandoh, Shuji, Fujita, Jiro, Ohtsuki, Yuji, Ueda, Yutaka, Hojo, Satoko, Tokuda, Michiaki, Dobashi, Hiroaki, Kurata, Noriyuki, Yoshinouchi, Takeo, Kohno, Nobuoki, Takahara, Jiro
• Format: Article
• Language: English
• Subjects: Acute Disease; Adult; Aged; Antigens; Antigens, Neoplasm; Biological and medical sciences; Biomarkers - blood; Biopsy; Cytokines; Dermatomyositis - blood; Dermatomyositis - complications; dermatomyositis/polymyositis; diffuse alveolar damage; Disease Progression; Extended Report; Female; Glycoproteins; Humans; Immunoenzyme Techniques; interstitial pneumonia; KL-6; Lung - metabolism; Lung diseases; Lung Diseases, Interstitial - blood; Lung Diseases, Interstitial - etiology; Male; Medical sciences; Middle Aged; Molecular weight; Mucin-1; Mucins - blood; Peptide Fragments - blood; Physiology; Pneumonia; Procollagen - blood; Rodents; Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis
• ISSN: 0003-4967; 1468-2060
• DOI: 10.1136/ard.59.4.257

OBJECTIVE KL-6 is a mucin-like high molecular weight glycoprotein, which is strongly expressed on type II alveolar pneumocytes and bronchiolar epithelial cells. It has been demonstrated that the KL-6 antigen is a useful marker for estimating the activity of interstitial pneumonia. In this study, it is hypothesised that serum KL-6 is a useful marker to evaluate the activity of interstitial pneumonia associated with polymyositis/dermatomyositis (PM/DM). METHODS KL-6 was measured in sera in 16 patients diagnosed with PM/DM. Five had non-specific interstitial pneumonia (NSIP), three had diffuse alveolar damage (DAD), and eight had no pulmonary involvement, and 10 were normal non-smokers as a control group. The correlation was also evaluated between the KL-6 level and each clinical course in patients with pulmonary involvement associated with PM/DM. Immunohistochemical analysis using monoclonal anti-KL-6 antibody was also performed. RESULTS KL-6 concentrations in sera of patients with interstitial pneumonia associated with PM/DM were significantly high compared with those of PM/DM without interstitial pneumonia, and normal non-smokers. KL-6 concentrations in sera in patients with DAD significantly increased compared with those of other groups. KL-6 values in sera changed according to the progression or improvement of interstitial pneumonia. Immunohistochemical study using pulmonary tissues obtained from patients with DAD demonstrated that the hyaline membrane, proliferating type II pneumocytes, bronchial epithelial cells and some endothelial cells in pulmonary veins were stained by antihuman KL-6 antibody. CONCLUSION These data demonstrate that measurement of serum KL-6 was a useful marker to evaluate the activity of acute interstitial pneumonia associated with PM/DM.